Rocket Lab USA Inc (NASDAQ: RKLB) Recovers 276.08% From 52-Week Low, Is RKLB Still A High-Risk, High-Reward Play?

Rocket Lab USA Inc (NASDAQ:RKLB) currently has a daily average trading volume of 14.56M but it saw 17326331 shares traded in last market. With a market cap of 6.48B USD, the company’s current market price of $13.05 came rising about 10.50 while comparing to the previous closing price of $11.81. In past 52 weeks, the stock remained buoying in the range of price level as high as $12.09 and as low as $3.47. In the recent trading on the day, stock has struck highest price mark of $12.07 while lowest mark touched by it was $13.06.

Taking a look at 20-day trading activity of Rocket Lab USA Inc (RKLB) gives us an average price of $10.96, while its current price level is 7.99% below from 52-week high level whereas it is 276.08% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $9.00 while that of 200 days or SMA-200 reads an average of $5.70. A closer look into the stock’s movement over the week reveals that its volatility is standing at 5.83% during that period while stretching the period over a month that increases to 6.13%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 74.66 which implies that the stock is in overbought territory.

Morgan Stanley downgraded its recommendation for the stock as a “Equal-Weight” from “Overweight” on July 15, 2024 while assigning a price target range of $8-$6.

Over the week, RKLB’s stock price is moving 19.07% up while it is 38.68% when we observe its performance for the past one month. Year-to-date it is 135.99% up and over the past year, the stock is showing an upside performance of 200.00%.

Currently, Rocket Lab USA Inc’s total number of outstanding shares is 488.92M. Company’s return on investment (ROI) stands at -19.28% and return on equity (ROE) at -33.19%. Stock’s beta reads 1.30. Stock has a price to book (P/B) ratio of 14.23 while price to sale or P/S ratio amounts to 19.84. Its return on asset (ROA) is -16.31% on average.